Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING
-
NEW NORTH AMERICAN ZERO-EMISSION COMMERCIAL TRUCK BRAND ZM TRUCKS TO DEBUT AT ACT EXPO
-
Electrosoft CEO Dr. Sarbari Gupta Honored with 2024 WIT Leadership Award
-
OmniAb to Participate in the Jefferies Global Healthcare Conference
-
Ameresco Awarded $21 Million Contract to Illuminate Henderson's Streets with State-of-the-Art LED Technology
-
Farmers & Merchants Bank of Long Beach Declares Second-Quarter Cash Dividend Payment of $28 Per Share
-
Polly Integrates with nCino's Mortgage Suite to Streamline Pricing and Enable Better Loan Officer Mobility
-
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
-
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease
-
Jeepers Go Topless to Raise Money for Charity
-
Silfab Solar Advances Made-in-USA Solar Cell Program with $20 Million Project and U.S. Department of Energy Award
-
4 Organizations Partner to Champion Safe Sleep for Babies
-
MAY HARVARD CAPS / HARRIS POLL: TRUMP LEADS BIDEN BY 5 POINTS AS 44% OF INDEPENDENTS ARE STILL WEIGHING THE CHOICES
-
Avelo Airlines Uncorks New 'Wine Travels Free' Program on Flights from the Bay Area/Sonoma County Airport
-
Netlist Prevails in Federal Court Against Samsung
-
PIZZA HUT ANNOUNCES KALEN THORNTON AS GLOBAL CHIEF BRAND OFFICER
-
Sequans Cassiopeia CA410 Module Awarded Industry Certification and Completes Successful Utility Field Testing
-
Bob Dake Named Principal at Sterling Organization
-
CBIH Engages Prestigious Law Firm for its First Patent Applications
-
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
-
CyberCatch Announces Partnership with FoxWise to Expand Distribution of its Solutions in Canada
-
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $4.0 Million
-
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation For Potential Securities Violations and Breaches of Fiduciary Duty
-
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
-
OpenFinity: The Premier Destination for Open Banking and Open Finance
-
Leoguar Bikes Taps Into 30-Year Manufacturing Expertise to Set New Standards in E-Bike Design and Quality
-
INMARSAT LAUNCHES NEXUSWAVE: A GAME-CHANGING 'BONDED' NETWORK SERVICE FOR MARITIME COMMUNICATIONS
-
MARS WRIGLEY NAMES TOPEKA ITS HALLOWEEN HEADQUARTERS, CELEBRATING A DECADE OF PARTNERSHIP WITH TOPEKA COMMUNITY
-
King Street Acquires Majority Interest in Colovore, a Leading Liquid-Cooled AI Data Center Operator
-
U.S. Food and Drug Administration (FDA) Extends its Memorandum of Understanding (MOU) with MedISAO
-
V2X Sites Earn Top Honors by Defense Information Systems Agency
-
Kimbell Royalty Partners Mourns the Passing of Board Member Ben J. Fortson
-
Seacoast Bank Welcomes Tony Coley as Regional President, South Florida
-
Global Telesat Begins Sales of SpaceX's Starlink as Authorized Reseller Through Joint Venture Agreement with Pivotel Solutions Inc. (dba Pulsar)
-
Prosper Gold Provides Update on Option Agreement to Acquire the Kaza and Northstar Properties
-
Sanctuary Wealth Commences Next Stage of Digital Strategy with Appointment of Robert Coppola As Chief Technology Officer
-
Ispire Technology Inc. Names Jim McCormick as CFO; Upgrades Global Executive Leadership to Drive Company's Expansion
-
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
-
Record results for Turpaz Industries group in revenues, gross profit and EBITDA in the first quarter of 2024
-
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau) for the Diagnosis of Progressive Supranuclear Palsy
-
Independent Analysis Finds Average Title Insurance Claim Cost for Fraud and Forgery is $143,000
-
Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
-
Zehnder’s of Frankenmuth Announces Future Plans
-
Sow Good to Ring the Nasdaq Opening Bell Today, May 20, 2024
-
Glia Launches First Responsible AI Platform Purpose Built for Financial Institutions
-
ClearOne, Inc. Reports First Quarter 2024 Financial Results
-
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile X Syndrome
-
Cireson Continues to Prioritize Compliance for Tikit with SOC 2 Achievement
-
Essen Health Care Launches Innovative Program to Support Individuals with Mental Illness
-
Charleston Water Taxi Puts Yamaha Outboards to the Test
